Health AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 2 DATA FOR INVESTIGATIONAL OLPASIRAN IN ADULTS WITH ELEVATED LIPOPROTEIN(a) May 31, 2022
Biotechnology BioMarin Announces Durable Hemostatic Efficacy Maintained Over 6 years in Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec, Investigational Gene Therapy for Hemophilia A May 31, 2022
Health Denali Therapeutics and Biogen Announce Initiation of Phase 2b Study of LRRK2 Inhibitor in Parkinson’s Disease May 31, 2022
Biotechnology argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis May 31, 2022
Search
Health
